▽elotuzumab - PubMed - NCBI ●01/08 13:44 Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.Lonial S, Dimopoulos M, Palumbo A, White D, Grosicki S, Spicka I, Walter-Croneck A, Moreau P, Mateos MV, Magen H, Belch A, Reece D, Beksac M, Spencer A, Oakervee H, Orlowski RZ, Taniwaki M, R〓llig C, Einsele H, Wu KL, Singhal A, San-Miguel J, Matsumoto M, Katz J, Bleickardt E, Poulart V, Anderson KC, Richardson P; ELOQUENT-2 Investiga
▽everolimus - PubMed - NCBI ●01/08 13:37 2024 4062025 139,442 resultsPage of 9459,442 resultsPage of 945of 945
▽obatoclax mesylate - PubMed - NCBI ●01/08 13:19 An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies.Goard CA, Schimmer AD. Goard CA, et al. Core Evid. 2013;8:15-26. doi: 10.2147/CE.S42568. Epub 2013 Mar 14. Core Evid. 2013. PMID: 23515850 Free PMC article.Obatoclax mesylate is an intravenously-administered drug under investigation in Phase I and II clinical trials as a novel anticancer therapeutic for
